• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Gene by Gene Acquires Arpeggi To Accelerate DNA Sequencing & Clinical Genomics

by Fred Pennic 08/07/2013 7 Comments

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Merger will make DNA sequencing and clinical genomics more accessible and affordable to all. 

Gene by Gene, Ltd., the leading developer of consumer DNA testing products for ancestry and genealogy applications, announced today the acquisition of Arpeggi, Inc., a StartUp Health- and GE-backed startup that develops solutions for genome sequencing, data management and computational analysis.

The announcement also represents the first successful exit of one of StartUp Health’s portfolio companies signaling how well their program is working to successfully accelerate and scale digital health startups.

The new combined company will be a major competitor to companies like 23andme and offer the consumer market much greater access and affordability to DNA testing and sequencing services. Gene by Gene plans to leverage Arpeggi’s infrastructure to assist human genomic and bioinformatics companies get the most out of their data.

arpeggi

Arpeggi was founded in 2012 by CEO Nir Leibovich, previously a product manager for San Francisco-based game maker Zynga Inc. and co-founder of Austin-based MarketZero Inc., which was acquired by Zynga in 2011. The Austin-based startup develops proprietary sequencing tools, designed for scale, that enable accurate, fast, and cost-effective analysis of genomes. Back in April, the startup released GCAT – Genome Comparison and Analytic Testing, a free community driven platform for evaluating the performance of next-generation sequencing (NGS) data analysis methods. Arpeggi was selected as one of 14 startups to join the Startup Health and GE Entrepreneurship Program to help grow, commercialize and scale new innovative healthcare technologies.

The entire Arpeggi team and technology platform will be incorporated into Gene by Gene. Additionally, Arpeggi’s founders will join Gene By Gene’s management team, effective immediately. Arpeggi’s Nir Leibovich was named Gene By Gene’s Chief Business Officer, Jason Wang was named Chief Technology Officer and David Mittelman, Ph.D was named Chief Scientific Officer. Gene by Gene’s Doron Behar, M.D., Ph.D. was also named Chief Medical Officer. Gene By Gene’s Blankfeld and Bennett Greenspan continue to serve as the company’s Managing Partners.

Financial terms of the transaction were not disclosed.

Gene by Gene will now join the Startup Health and GE’s three year program to assist them in growing and scaling the company forward.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Startup Health

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |